Survival rate of patients with relapsed ALL after hematopoietic cell transplantation has steadily increased

For patients with acute lymphoblastic leukemia (ALL) carrying the Philadelphia chromosome and whose disease relapsed after allogeneic hematopoietic stem cell transplantation (HCT), the two-year overall survival rate has nearly doubled from the period between 2000 and 2004 to the period between 2015 and 2019, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

source https://medicalxpress.com/news/2022-01-survival-patients-relapsed-hematopoietic-cell.html